封面
市場調查報告書
商品編碼
1550667

全球生命科學 BPO 市場:依服務類型、最終用戶、地區

Life Sciences BPO Market, By Service Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球生命科學 BPO 市場規模預計將從 2024 年的 4,081 億美元增加到 2031 年的 9,722 億美元,2024 年至 2031 年複合年成長率為 13.2%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 4081億美元
實際資料 2019-2023 預測期 2024-2031
預測 2024-2031 年複合年成長率: 13.20% 2031年價值預測 9722億美元
圖:2024 年生命科學 BPO 市場佔有率(按地區分類)
生命科學 BPO 市場-IMG1

生命科學 BPO 市場由向醫療保健產業提供的外包服務組成,包括製藥公司、生技公司和醫療設備公司。我們幫助生命科學公司專注於藥物發現、產品開發和商業化的核心業務。監管事務管理、臨床資料管理、醫學寫作和出版、藥物安全檢測、醫學監測和其他臨床試驗相關服務等服務委託給專業的 BPO 提供者。成本最佳化、先進基礎設施和專業知識的獲取、複雜的法律規範以及簡化業務的需求等因素正在增加生命科學領域的外包。

市場動態:

全球生命科學 BPO 市場的成長是由生命科學公司不斷成長的成本最佳化需求以及 BPO服務供應商提供的先進基礎設施和專業知識帶來的好處所推動的。此外,藥物開發和核准的法律規範逐年變得更加複雜,因此有必要外包非核心職能。醫療保健產業動態的變化,例如向基於價值的照護的轉變,也促使生命科學公司透過策略性外包來簡化業務。然而,資料安全問題、關鍵功能失控以及與供應商管理相關的營運挑戰等因素可能會阻礙市場成長。新興市場醫療保健支出的增加、生物相似藥和基因組藥物的開發以及人工智慧/區塊鏈的整合以增強 BPO 服務可能為市場成長提供機會。

本研究的主要特點

該報告對全球生命科學 BPO 市場進行了詳細分析,並以 2023 年為基準年估計了預測期內(2024-2031 年)的市場規模(十億美元)和年複合成長率(CAGR%)。

它還揭示了各個細分市場的潛在商機,並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、關鍵亮點、績效和策略等參數對全球生命科學 BPO 市場的主要企業進行了分析。

本研究涵蓋的主要企業包括 Cognizant、Accenture、簡柏特、EXL services、康泰倫特等。

該報告的見解將幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球生命科學 BPO 市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球生命科學 BPO 市場的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章全球生命科學 BPO 市場 - 新冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章全球生命科學 BPO 市場:依服務類型(2019-2031)

  • 醫藥外包
  • API
  • 完整劑型
  • 包裝
  • 藥物發現
  • 臨床前研究
  • 臨床試驗研究
  • 監管服務
  • 藥物警戒
  • 醫療設備外包
  • 電子設備製造服務
  • 成品
  • 原料/零件
  • 監理諮詢服務
  • 產品設計及開發服務
  • 產品測試服務
  • 產品實施服務
  • 產品升級服務
  • 產品維修服務
  • 合約銷售和市場外包
  • 其他

第6章全球生命科學 BPO 市場:依最終使用者分類(2019-2031)

  • 製藥公司
  • 生技公司
  • 合約研究組織
  • 醫療設備公司
  • 學術和政府機構

第7章全球生命科學 BPO 市場:按地區(2019-2031)

  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東

第8章 競爭格局

  • 公司簡介
    • Accenture, Plc
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab Biotechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

第9章 分析師建議

  • Wheel of Fortune
  • 分析師觀點
  • Coherent Opportunity Map(COM)

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI24

Global life sciences BPO market is estimated to be valued at USD 408.1 Bn in 2024 and is expected to reach USD 972.2 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 408.1 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 13.20% 2031 Value Projection: US$ 972.2 Bn
Figure. Life Sciences BPO Market Share (%), By Region 2024
Life Sciences BPO Market - IMG1

The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development and commercialization. Services like regulatory affairs management, clinical data management, medical writing and publishing, pharmacovigilance, medical monitoring and other clinical trial related services are outsourced to specialized BPO players. Factors such as cost optimization, access to advanced infrastructure and expertise, complex regulatory frameworks and need to streamline operations has increased outsourcing in the life sciences sector.

Market Dynamics:

Global life sciences BPO market growth is driven by rising need for cost-optimization among life sciences companies coupled with benefits of access to advanced infrastructure and expertise delivered by BPO service providers. Moreover, regulatory frameworks for drug development and approval have become highly complex over the years, thus, necessitating outsourcing of non-core functionalities. Changing dynamics of the healthcare industry including shift towards value-based care has also prompted life sciences players to streamline their operations through strategic outsourcing. However, factors such as data security concerns, loss of control over critical functions and operational challenges associated with vendor management can hamper the market growth. Growing healthcare expenditure in developing regions, development of biosimilars & genomic drugs and integration of AI/blockchain to enhance BPO services can offer market growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global life sciences BPO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global life sciences BPO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Cognizant, Accenture, Genpact, EXL services, and Catalent

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global life sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life sciences BPO market

Detailed Segmentation-

  • By Service Type
    • Pharmaceutical outsourcing
    • Contract manufacturing market
    • API
    • Finished dose form
    • Packaging
    • Contract research organizations
    • Drug discovery
    • Preclinical studies
    • Clinical trial studies
    • Regulatory services
    • Pharmacovigilance
    • Medical devices outsourcing
    • Contract manufacturing market
    • Electronic manufacturing services
    • Finished goods
    • Raw materials/components
    • Contract research organizations
    • Regulatory consulting services
    • Product design and development services
    • Product testing services
    • Product implementation services
    • Product upgrade services
    • Product maintenance services
    • Contract sales & market outsourcing
    • Others
  • By End User
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations Medical Device Companies
    • Academic Institutes & Government Organizations
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Accenture, Plc
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab Biotechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Life Sciences BPO Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Life Sciences BPO Market, By Service Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Pharmaceutical outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
    • Contract manufacturing market
  • API
  • Finished dose form
  • Packaging
    • Contract research organizations
  • Drug discovery
  • Preclinical studies
  • Clinical trial studies
  • Regulatory services
  • Pharmacovigilance
  • Medical devices outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
    • Contract manufacturing market
  • Electronic manufacturing services
  • Finished goods
  • Raw materials/components
    • Contract research organizations
  • Regulatory consulting services
  • Product design and development services
  • Product testing services
  • Product implementation services
  • Product upgrade services
  • Product maintenance services
  • Contract sales & market outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Life Sciences BPO Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Device Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic Institutes & Government Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Life Sciences BPO Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Accenture, Plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab Biotechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact